Latest Updates and Innovations: 
News & Videos

We keep you informed with the latest breakthroughs, updates, and stories from Cercare Medical. Dive into our articles to discover how we're pushing the boundaries of perfusion imaging, learn about our recent projects, and hear from the experts leading the way. Stay connected with the innovations and insights shaping the future of medical imaging.

Recent Posts

Basel, Switzerland

MAY 15th.-17th. , 2024
BOOTH N° B11

Leif Østergaard
Scientific board member

Cercare Medical Releases Version 17 of Neurosuite: Advancing Precision and Efficiency in Neuroimaging

Cercare Medical Releases Version 17 of Neurosuite: Advancing Precision and Efficiency in Neuroimaging

04/06/2025
PRESS RELEASE Cercare Medical Releases Version 17 of Neurosuite: Advancing Precision and Efficiency in Neuroimaging Latest update includes new, improved tools for more precise tumor assessment and stroke care. AARHUS, DENMARK, 4 June 2025: Cercare Medical, a leader in advanced neuroimaging software, is proud to announce the launch of CERCARE MEDICAL NEUROSUITE (CMN) Version 17. […]
Read
Cercare Medical Secures FDA Clearance for CT Perfusion Imaging Software

Cercare Medical Secures FDA Clearance for CT Perfusion Imaging Software

12/12/2024
PRESS RELEASE Cercare Medical Secures FDA Clearance for CT Perfusion Imaging Software Milestone Achievement Expands Availability of Advanced Perfusion Imaging in Stroke Care. AARHUS, DENMARK, 12 Dec 2024: Cercare Medical is proud to announce FDA clearance for its CT perfusion imaging software, a significant milestone that complements the existing clearance for MRI perfusion imaging. This achievement underscores […]
Read
PRESS RELEASE: Groundbreaking Study Highlights Cercare Medical’s Role in Stroke Treatment Innovations

PRESS RELEASE: Groundbreaking Study Highlights Cercare Medical’s Role in Stroke Treatment Innovations

27/11/2024
PRESS RELEASE Groundbreaking Study Highlights Cercare Medical’s Role in Stroke Treatment Innovations Lyon Team's Study, Led by Dr. Bani-Sadr, Demonstrates How Advanced Biomarkers are Transforming Stroke Care. AARHUS, DENMARK, 27 Nov 2024: Cercare Medical proudly announces that a new study led by Dr. Alexandre Bani-Sadr and his team in Lyon, published on the front page of […]
Read
Advanced Biomarker Improves Diagnostics in Stroke and Oncology 🔍 

Advanced Biomarker Improves Diagnostics in Stroke and Oncology 🔍 

05/07/2024
Stroke ManagementM1 occlusionOEF increase Oncology Glioblastoma tumor recurrenceOEF increase Have you ever heard about Oxygen Extraction Fraction (OEF)? It’s an important biomarker in Cercare Medical Neurosuite software that ensures high-quality perfusion maps. In the world of advanced diagnostic imaging, the measurement of OEF is emerging as a critical indicator in diverse clinical settings, including stroke […]
Read
Cercare Medical News: Revolutionizing Stroke Care: Cercare Medical Debuts CMN Version 14

Cercare Medical News: Revolutionizing Stroke Care: Cercare Medical Debuts CMN Version 14

07/03/2024
Cercare Medical News: Revolutionizing Stroke Care: Cercare Medical Debuts CMN Version 14 Aarhus, Denmark - Embrace the future of stroke diagnosis with the launch of Cercare Medical Neurosuite (CMN) Version 14. This landmark release heralds a new era in precision neuroimaging, bringing forth groundbreaking features that promise to transform stroke management and patient care. René […]
Read
Cercare Medical News: Celebrating Innovative Collaboration with Fondation Rothschild Hospital

Cercare Medical News: Celebrating Innovative Collaboration with Fondation Rothschild Hospital

02/02/2024
Cercare Medical News: Celebrating Innovative Collaboration with Fondation Rothschild Hospital Cercare Medical is thrilled to announce a groundbreaking collaboration with the esteemed Fondation Rothschild Hospital. Our pioneering medical imaging software has been seamlessly integrated, marking a monumental stride in our mission to revolutionize medical diagnostics and elevate patient care on a global scale. Cercare Medical […]
Read
Meet us @Billeddiagnostisk Årsmøde 2024

Meet us @Billeddiagnostisk Årsmøde 2024

24/01/2024
Meet us @Billeddiagnostisk Årsmøde 2024 Cercare Medical to Illuminate Billeddiagnostisk Årsmøde 2024 with Innovative Imaging Solutions Cercare Medical is thrilled to announce our distinguished participation in the Billeddiagnostisk Årsmøde 2024, an esteemed forum for cutting-edge advancements in diagnostic imaging and medical technology. This pivotal event brings together experts and innovators from across the globe, and […]
Read
Cerebrovascular Reserve in Moyamoya Disease: Relation to Cerebral Blood Flow, Capillary Dysfunction, Oxygenation, and Energy Metabolism.”

Cerebrovascular Reserve in Moyamoya Disease: Relation to Cerebral Blood Flow, Capillary Dysfunction, Oxygenation, and Energy Metabolism.”

20/07/2023
Cerebrovascular Reserve in Moyamoya Disease: Relation to Cerebral Blood Flow, Capillary Dysfunction, Oxygenation, and Energy Metabolism." Exciting New Study! Gaining Deeper Insights into Moyamoya Disease with Cercare Medical's Neurosuite (CMN)! Scientific ReportThe study investigated the association of cerebrovascular reserve (CVR) with various cerebral hemodynamic and energy metabolic parameters in Moyamoya disease (MMD), using perfusion imaging […]
Read

Tab Content

This is a basic text element.

Ready to Transform Your Diagnostic Capabilities?

Join Us in Advancing Brain Health with Cutting-Edge Microvascular Modeling.
Contact Us Today to Learn More!
Contact us
Cercare Medical A/S
Inge Lehmanns Gade 10
8000 Aarhus C
Denmark

Solutions
Cercare Perfusion Neuro & Oncology Stroke Modules
Support
Assistance Instructions for Use Distributor Portal
Company
Board Members Investors About News Career Privacy Policy Regulatory & Compliance
© 2026 Cercare Medical. All rights reserved.
TRY US

CLINICAL USE CASES AND TECHNICAL HIGHLIGHTS


CLINICAL USE CASES
  • Directly impacts the patient treatment pathway, both intra- and post-intervention.
  • Assess outcomes post-intervention: detect missed stenoses, distal occlusions, or microvascular disturbances.
  • Guide complementary therapies on the spot based on perfusion status.
  • May detect the no-reflow phenomenon — providing insight into cases where recovery may fail despite successful thrombectomy.
  • Potentially enables direct-to-angio workflows.

TECHNICAL HIGHLIGHTS
  • Full set of perfusion markers: CBF, CBV, MTT.
  • Advanced oxygen metabolism imaging: OEF, CMRO₂.
  • Most reliable results with 10 CBCT acquisitions.
  • Vendor-agnostic platform.

CBCT Imaging

Side-by-side comparison: The left-hand side is the raw CBCT data, while the right-hand side panel is the pre-processed data.
Using CMN software in the angio suite delivers results comparable to conventional CT/MR perfusion.

Contact us:

A Cercare Medical Representative will reach out to you directly to assist with your inquiry.

Sign up for the upcoming Perfusion & Metabolic Imaging Community (PMIC)

Imaging

MTT

SVD model

MTT

Vascular Model

T2 FLAIR

follow-up image
Perfusion maps of a stroke patient show a large difference in lesion appearance compared to the SVD technique, where the VM appears in better correspondence with the T2 FLAIR follow-up.

MTT

SVD model

MTT

Vascular Model

T2 FLAIR

follow-up image
The modest degree of tissue involvement is consistent with the
moderate neurologic deficits, National Institutes of Health Stroke
Scale (NIHSS) = 4.

Request a Demo

Let us give you a tour around our solution.

Fill in your credentials, and a member of the Cercare Medical team will contact you with a date and time proposal that fits your schedule.

Explore CMN!

Fast. Reliable. Personalized.

Discover how Cercare Medical Neurosuite (CMN) enhances post-processing images and provides actionable insights from advanced biomarkers - tailored to your workflow.

Fill-out the form below, and a representative will contact you.

Thank you for uploading your DICOM files.

Your submission has been received successfully.

Next steps:

  • Our team will analyze the uploaded data.
  • A Cercare Medical representative will reach out to you once the analysis is complete.
  • Rest assured that all files will be deleted immediately after use, in line with our data protection policies.
})